Edition:
United States

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.12USD
15 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.12
Open
$1.14
Day's High
$1.16
Day's Low
$1.12
Volume
29,842
Avg. Vol
37,964
52-wk High
$3.06
52-wk Low
$1.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.258
Jun '17 0.00 -0.232
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -0.344
Sep '16 0.00 -0.426
Jun '16 0.00 -0.493
Mar '16 0.00 0.910
FY 2015 Dec '15 0.00 1.107
Sep '15 0.00 -2.457
Jun '15 0.00 -3.023
Mar '15 0.00 -3.043
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 10.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.23 -0.23 -0.23 --
Quarter Ending Mar-18 1 -0.23 -0.23 -0.23 --
Year Ending Dec-17 1 -0.96 -0.96 -0.96 -0.83
Year Ending Dec-18 1 -0.96 -0.96 -0.96 0.14
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.50 36.03
P/E High - Last 5 Yrs. -- 40.74 45.26
P/E Low - Last 5 Yrs. -- 23.65 24.26
Beta 0.99 0.92 0.91
Price to Sales (TTM) -- 3.97 5.90
Price to Book (MRQ) 1.99 4.92 5.74
Price to Tangible Book (MRQ) 2.99 5.79 7.33
Price to Cash Flow (TTM) -- 23.36 24.72
% Owned Institutions 5.55 0.85 1.38

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) -- 47.43 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.29 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 5.09 5.56
Sales - 5 Yr. Growth Rate -- 10.01 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.52 7.08 7.88
EPS (TTM) vs TTM 1 Yr. Ago -197.81 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.92
Capital Spending - 5 Yr. Growth Rate -9.41 15.14 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 3.14 3.51 3.57
LT Debt to Equity (MRQ) 0.04 10.90 13.26
Total Debt to Equity (MRQ) 0.08 16.99 19.22
Interest Coverage (TTM) -- 49.07 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.21 54.87
Gross Margin - 5 Yr. Avg. -- 52.33 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.52 15.70
Operating Margin (TTM) -- 14.76 6.77
Operating Margin - 5 Yr. Avg. -- 14.36 11.08
Pre-Tax Margin (TTM) -- 15.22 7.60
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 11.49
Net Profit Margin (TTM) -- 11.39 3.83
Net Profit Margin - 5 Yr. Avg. -- 11.00 7.78
Effective Tax Rate (TTM) -- 24.37 24.27
Effective Tax Rate - 5 Yr. Avg. -- 23.47 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 951,233,490 857,902,259
Net Income/Employee (TTM) -804,579 111,321,846 100,310,105
Receivable Turnover (TTM) -- 5.91 6.13
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.00 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -125.93 11.90 11.35
Return on Assets - 5 Yr. Avg. -75.22 12.90 12.32
Return on Investment (TTM) -154.64 15.11 14.48
Return on Investment - 5 Yr. Avg. -115.63 16.87 16.13
Return on Equity (TTM) -157.67 16.59 16.06
Return on Equity - 5 Yr. Avg. -127.41 17.87 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.55%
# of Holders: 17
Total Shares Held: 877,478
3 Mo. Net Change: -101,443
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 4
# Reduced Positions: 7
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.